lea ament, left, and tamara nunley talk about the care their team provided for helen and robert valenzuela at st. jude medical center in fullerton. (scott smeltzer / staff photographer)
.
.
u.s.
. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.
.
.
when robert had to go on full medical disability in his early 50s after hurting himself at work, helen went back to work, this time in the oil industry.
.